RT Journal Article
SR Electronic
A1 Kuznar, Wayne
T1 Initial Triple Therapy Superior to Monotherapy on Measures of Disease Activity in RA
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 18
SP 14
OP 15
DO 10.1177/155989771318004
UL http://mdc.sagepub.com/content/13/18/14.abstract
AB Triple disease-modifying antirheumatic drug (DMARD) therapy is superior to methotrexate monotherapy on measures of disease activity as initial treatment for rheumatoid arthritis (RA). The design and results of the multicenter stratified single-blind Treatment in the Rotterdam Early Arthritis Cohort trial [tREACH] comparing treatment strategies, including different glucocorticoid bridging therapies, in adults with early RA are discussed in this article